NCT01524302View on ClinicalTrials.gov

Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia

PHASE4CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

April 30, 2015

Conditions

Pneumonia, BacterialCommunity-acquired

Interventions

DRUG

Ceftaroline

600 mg Q12h

DRUG

Levofloxacin

750 mg QD

Trial Locations (1)

Unknown

Sparrow Hospital, Lansing

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Gary E. Stein, Pharm.D.

OTHER